Publications by authors named "Benjamin Ettle"

Claim this Profile
N
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab.
Tjalf Ziemssen, Marie Groth, Benjamin Ettle, Tobias Bopp

Hum Vaccin Immunother· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis.
Tjalf Ziemssen, Eugen Schlegel, Marie Groth, Benjamin Ettle, Tobias Bopp

Vaccines (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Response to SARS-CoV-2 mRNA Vaccines in an Open-Label Multicenter Study in Participants with Relapsing Multiple Sclerosis Treated with Ofatumumab.
Tjalf Ziemssen, Marie Groth, Benjamin Ettle, Tobias Bopp

Vaccines (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany.
Tjalf Ziemssen, Michael Lang, Stephan Schmidt, Holger Albrecht, Luisa Klotz, Benjamin Ettle

J Neurol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the long-term clinical and economic impact of ofatumumab versus dimethyl fumarate and glatiramer acetate in patients with relapsing multiple sclerosis: A cost-consequence analysis from a societal perspective in Germany.
Dominik Koeditz, Juergen Frensch, Martin Bierbaum, Nils-Henning Ness, Benjamin Ettle

Mult Scler J Exp Transl Clin· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients.
Tjalf Ziemssen, Holger Albrecht, Judith Haas, Luisa Klotz, Michael Lang, Benjamin Ettle

Front Neurol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transitional phase of multiple sclerosis: The concept of PANGAEA 2.0 evolution study.
Hernan Inojosa, Benedict Rauser, Benjamin Ettle, Tjalf Ziemssen

Mult Scler Relat Disord· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence on the Societal Economic Relapse Costs in Patients with Multiple Sclerosis.
Nils-Henning Ness, Dirk Schriefer, Rocco Haase, Benjamin Ettle, Tjalf Ziemssen

Pharmacoeconomics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Real-World Evidence on the Patterns of Increased Societal Economic Relapse Costs in Patients with Multiple Sclerosis.
Nils-Henning Ness, Dirk Schriefer, Rocco Haase, Benjamin Ettle, Tjalf Ziemssen

Pharmacoeconomics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiating societal costs of disability worsening in multiple sclerosis.
Nils-Henning Ness, Dirk Schriefer, Rocco Haase, Benjamin Ettle, Christian Cornelissen

J Neurol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term real-world evidence for sustained clinical benefits of fingolimod following switch from natalizumab.
Tjalf Ziemssen, Michael Lang, Björn Tackenberg, Stephan Schmidt, Holger Albrecht, Benjamin Ettle

Mult Scler Relat Disord· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Differentiating societal costs of disability worsening in multiple sclerosis.
Nils-Henning Ness, Dirk Schriefer, Rocco Haase, Benjamin Ettle, Christian Cornelissen

J Neurol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Multiple Sclerosis Health Resource Utilization Survey (MS-HRS): Development and Validation Study.
Nils-Henning Ness, Rocco Haase, Raimar Kern, Dirk Schriefer, Benjamin Ettle

J Med Internet Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Alana Hoffmann, Benjamin Ettle, Kristina Battis, Simone Reiprich, Johannes C M Schlachetzki

Brain Pathol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha-synuclein activates BV2 microglia dependent on its aggregation state.
Alana Hoffmann, Benjamin Ettle, Ariane Bruno, Anna Kulinich, Anna-Carin Hoffmann

Biochem Biophys Res Commun· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
Benjamin Ettle, Kristina Kuhbandner, Stefanie Jörg, Alana Hoffmann, Jürgen Winkler

J Neuroinflammation· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?
Benjamin Ettle, Johannes C M Schlachetzki, Jürgen Winkler

Mol Neurobiol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Benjamin Ettle, Bilal E Kerman, Elvira Valera, Clarissa Gillmann, Johannes C M Schlachetzki

Acta Neuropathol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopaminergic lesioning impairs adult hippocampal neurogenesis by distinct modification of α-synuclein.
Johannes C M Schlachetzki, Thomas Grimm, Zinayida Schlachetzki, Nada M B Ben Abdallah, Benjamin Ettle

J Neurosci Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
Janina Deusser, Stefanie Schmidt, Benjamin Ettle, Sonja Plötz, Sabine Huber

J Neurochem· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hippocampal structure and function are maintained despite severe innate peripheral inflammation.
Patrick Süß, Liubov Kalinichenko, Wolfgang Baum, Martin Reichel, Johannes Kornhuber, Benjamin Ettle

Brain Behav Immun· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.
Verena E L May, Benjamin Ettle, Anne-Maria Poehler, Silke Nuber, Kiren Ubhi

Neurobiol Aging· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracellular alpha-synuclein affects early maturation of primary oligodendrocyte progenitor cells.
Benjamin Ettle, Simone Reiprich, Janina Deusser, Johannes C M Schlachetzki, Wei Xiang

Mol Cell Neurosci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD.
Silke Nuber, Daniel Tadros, Jerel Fields, Cassia Rose Overk, Benjamin Ettle

Acta Neuropathol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.
Franz Marxreiter, Benjamin Ettle, Verena E L May, Hakan Esmer, Christina Patrick

Neurobiol Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis